United Drug, a pharmaceutical and healthcare services group, has entered an agreement to acquire Bilcare Global Clinical Supplies for $75 million. The acquisition, subject to certain closing conditions, is expected to be complete by the end of the month. Under the agreement, Bilcare will retain its clinical supplies business in Asia.
Bilcare Global Clinical Supplies provides clinical trial materials including formulation, development, packaging, labeling and supply chain management to global pharmaceutical and biotech manufacturers and CROs. The company has facilities in the U.S. and UK in Phoenixville, PA, and Crickhowell, Wales and employs195 people.
“The Bilcare acquisition is another very important step in the development of United Drug as we focus on margin expanding, international opportunities. This business fits well alongside our existing packaging businesses in the U.S. and Europe and will position us as a leading provider of services in the growing clinical trials materials market," said United chief executive Liam Fitzgerald.